Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
about
Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac DeathReview of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studiesEffect of IL-18 binding protein on hepatic ischemia-reperfusion injury induced by infrarenal aortic occlusion.Effects of statins on TH1 modulating cytokines in human subjects.Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.The Importance of NLRP3 Inflammasome in Heart FailureInflammatory Cytokines as Risk Factors for Mortality After Acute Cardiac Events.Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutationAssociation Between Interleukin-18 Level and Left Ventricular Mass Index in Hypertensive Patients.Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational conceptsInterleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse.Interleukin-18 increases TLR4 and mannose receptor expression and modulates cytokine production in human monocytes.Biomarkers of Endothelial, Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure.Linking the sympathetic nervous system to the inflammasome: towards new therapeutics for atherosclerotic cardiovascular disease.The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study.Increased Expression of Interleukin-18 mRNA is Associated with Carotid Artery Stenosis
P2860
Q26744359-C53241D8-0494-4396-9AAE-94489F307578Q26746907-8E3650F3-0A85-4909-807A-D2A50238E2C2Q35076516-8F79A014-3567-4685-8B92-27C7B120F297Q35081825-CB623734-7160-4CB5-8F3B-C4EBF980A7F9Q35847003-2D2DF353-CA24-4319-82B1-FF13CC753192Q35891957-17BB7BC2-5A35-4290-A512-E76D2BCC77CEQ37279845-8CC58C35-8A08-4976-BE93-ABB49F58312DQ37699393-7D29EA44-8751-44D5-8B09-7AF0E9495EE7Q37735377-FFAE9056-6C80-4C61-93F7-579474E7C0A9Q38566665-A2A85D48-5EEA-4752-AEC9-AC9D63CE94DAQ42258755-0D4349C0-0CD8-4CA4-9C6F-8BB0AF49B507Q43214205-ED86C08C-5F53-421B-97AE-3B76EDDA8DB6Q47248876-439A3B54-185B-42D9-A168-2B80D6A6283CQ50094089-A041920D-2463-4680-AB04-08B7A3135425Q52632607-C1302637-CC51-4084-84D5-24F90CA917C6Q53326416-EC967E1F-1BD4-4D99-AF1B-440234244353Q55232584-C33BEAAD-D380-4B4C-8D3F-43232840FBC5
P2860
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
@ast
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
@en
type
label
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
@ast
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
@en
prefLabel
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
@ast
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.
@en
P2093
P2860
P1433
P1476
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure
@en
P2093
Antonio Abbate
Benjamin W Van Tassell
Carlo Marchetti
Eleonora Mezzaroma
Laura C O'Brien
Stefano Toldo
P2860
P2888
P304
P356
10.2119/MOLMED.2014.00034
P407
P577
2014-06-12T00:00:00Z
P5875
P6179
1068965660